protacs: potential novel agents for the treatment of cll
Published 9 months ago • 126 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:01
novel combination therapies for the treatment of cll
-
2:04
how do we sequence and combine novel agent-based therapies in cll?
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:21
how the concept of fitness in cll has changed with the introduction of novel targeted agents
-
3:39
the role of novel therapies in r/r dlbcl
-
17:06
preoperative evaluation cataract surgery
-
1:59
epseama™ - the holistic skin rejuvenator
-
4:22
hematology/oncology - fellowship overview
-
1:44
novel combination therapies in cll
-
3:29
novel venetoclax combination therapy advancing the field of cll
-
1:14
novel inducers of apoptosis in double-refractory cll cells
-
2:36
choosing treatment options for cll and combining novel drugs
-
2:23
the importance of genomic testing in cll in the era of novel therapies
-
0:53
the future of cll treatment
-
1:10
cell expansion and vector design in novel t-cell therapies
-
16:12
exploring the potential of car-t therapy in cll
-
1:07
novel agents in cll: the current landscape
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
2:14
novel approaches to first line cll treatment
-
1:55
novel agents in cll: the importance of affordability
-
10:40
predictors in the novel therapy era
-
2:20
car-t therapy as a replacement for triple combination therapy in cll